Jennifer V. Nguyen

Jennifer V. Nguyen

Auto-generated profile, based on publicly available information

Jennifer V. Nguyen

Skaggs School of Pharmacy and Pharmaceutical Sciences, Center for Discovery and Innovation in Parasitic Diseases, University of California San Diego, La Jolla, California 92093, United States

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
VSVandna Sharma
Vandna Sharma
Valentina Noemi MadiaValentina Noemi Madia
Valentina Noemi Madia
VTValeria Tudino
Valeria Tudino
JNJennifer V. Nguyen
Jennifer V. Nguyen
Anjan DebnathAnjan Debnath
Anjan Debnath
LPLarissa M. Podust
Larissa M. Podust
Developing drugs for brain infection by Naegleria fowleri is an unmet medical need. We used a combination of cheminformatics, target-, and phenotypic-based drug discovery methods to identify inhibitors that target an essential N. fowleri enzyme, sterol 14-demethylase (NfCYP51). A total of 124 compounds preselected in silico were tested against N. fowleri. Nine primary hits with EC50 ≤ 10 μM were phenotypically identified. Cocrystallization with NfCYP51 focused attention on one primary hit, miconazole-like compound 2a. The S-enantiomer of 2a produced a 1.74 Å cocrystal structure. A set of analogues was then synthesized and evaluated to confirm the superiority of the S-configuration over the R-configuration and the advantage of an ether linkage over an ester linkage. The two compounds, S-8b and S-9b, had an improved EC50 and KD compared to 2a. Importantly, both were readily taken up into the brain. The brain-to-plasma distribution coefficient of S-9b was 1.02 ± 0.12, suggesting further evaluation as a lead for primary amoebic meningoencephalitis.

26 November 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
OHObaid Hayat
Obaid Hayat
NUNazif Ullah
Nazif Ullah
MSMuhammad Sirajuddin
Muhammad Sirajuddin
MGMiriam Giardini
Miriam Giardini
JNJennifer V. Nguyen
Jennifer V. Nguyen
Jair L. Siqueira-NetoJair L. Siqueira-Neto
Jair L. Siqueira-Neto
Metals have been used in medicine since ancient times for the treatment of different ailments with various elements such as iron, gold and arsenic. Metal complexes have also been reported to show antibiotic and antiparasitic activity. In this context, we tested the antiparasitic potential of 10 organotin (IV) derivatives from 4-(4-methoxyphenylamino)-4 oxobutanoic acid (MS26) against seven eukaryotic pathogens of medical importance: Leishmania donovani, Trypanosoma cruzi, Trypanosoma brucei, Entamoeba histolytica, Giardia lamblia, Naegleria fowleri and Schistosoma mansoni. Among the compounds with and without antiparasitic activity, compound MS26Et3 stood out with a 50% effective concentration (EC50) of 0.21 and 0.19 µM against promastigotes and intracellular amastigotes of L. donovani, respectively, 0.24 µM against intracellular amastigotes of T. cruzi, 0.09 µM against T. brucei, 1.4 µM against N. fowleri and impaired adult S. mansoni viability at 1.25 µM. In terms of host/pathogen selectivity, MS26Et3 demonstrated relatively mild cytotoxicity toward host cells with a 50% viability concentration of 4.87 µM against B10R cells (mouse monocyte cell line), 2.79 µM against C2C12 cells (mouse myoblast cell line) and 1.24 µM against HEK923 cells (human embryonic kidney cell line). The selectivity index supports this molecule as a therapeutic starting point for a broad spectrum antiparasitic alternative. Proteomic analysis of host cells infected with L. donovani after exposure to MS26Et3 showed a reduced expression of Rab7, which may affect the fusion of the endosome with the lysosome, and, consequently, impairing the differentiation of L. donovani to the amastigote form. Future studies to investigate the molecular target(s) and mechanism of action of MS26Et3 will support its chemical optimization.

9 November 2023 in ACS Infectious Diseases
Verified
Journal Article
Closed access
AYAlice Yuan
Alice Yuan
HFHayley Fong
Hayley Fong
JNJennifer V. Nguyen
Jennifer V. Nguyen
SNSophia Nguyen
Sophia Nguyen
PNPayton Norman
Payton Norman
Anjan DebnathAnjan Debnath
Anjan Debnath